Anti-CD4 antibodies in rheumatoid arthritis
Breedveld, F.C.; de Vries, R.R.
Clinical and Experimental Rheumatology 10(4): 325-326
1992
ISSN/ISBN: 0392-856X PMID: 1395216 Document Number: 402801
Document emailed within 1 workday
Related Documents
Sihvonen, S.; Korpela, M.; Mustila, A.; Mustonen, J. 2005: The predictive value of rheumatoid factor isotypes, anti-cyclic citrullinated peptide antibodies, and antineutrophil cytoplasmic antibodies for mortality in patients with rheumatoid arthritis Journal of Rheumatology 32(11): 2089-2094Kuru, O.; Bilgici, A.; Birinci, A.; Ulusoy, H.; Durupinar, B. 2009: Prognostic value of anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis Bratislavske Lekarske Listy 110(10): 650-654
Youinou, P.; Brousse, A.; Le Goff, P. 1984: Anti-histone antibodies in rheumatoid arthritis Revue du Rhumatisme et des Maladies Osteo-Articulaires 51(7-8): 419-420
Hayashi, N.; Kumagai, S. 2010: Anti-cyclic citrullinated peptide antibodies and rheumatoid arthritis Rinsho Byori. Japanese Journal of Clinical Pathology 58(5): 466-479
Toes, R.E.; van der Woude, D. 2011: ACPA (anti-citrullinated protein antibodies) and rheumatoid arthritis Acta Reumatologica Portuguesa 36(3): 205-207
Heurkens, A.H.; Hiemstra, P.S.; Lafeber, G.J.; Daha, M.R.; Breedveld, F.C. 1989: Anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated by vasculitis Clinical and Experimental Immunology 78(1): 7-12
Wanchu, A.; Deodhar, S.D.; Sharma, M.; Gupta, V.; Bambery, P.; Sud, A. 1997: Elevated levels of anti-proteus antibodies in patients with active rheumatoid arthritis Indian Journal of Medical Research 105: 39-42
Wakhlu, A.; Gupta, D.; Aggarwal, A.; Misra, R. 2003: Low levels of anti-histone antibodies in north Indian children with juvenile rheumatoid arthritis Indian Journal of Medical Research 118: 204-207
Ramírez, Súl.; Ramírez, Mía.G.; Muñoz, Jé.F.; Martínez, G.E.; Velarde, E.E.; Sánchez, P.E. 2019: Association of KIR2DL2 gene with anti-cyclic citrullinated protein antibodies for serodiagnosis in rheumatoid arthritis Medicina 79(3): 161-166
Caro-Oleas, J.L.; Fernández-Suárez, A.; Reneses Cesteros, S.; Porrino, C.; Núñez-Roldán, A.; Wichmann Schlipf, I. 2008: Evaluation of third generation anti-CCP antibodies in the diagnosis of rheumatoid arthritis from undifferentiated polyarthritis after 4 years of follow-up Clinical and Experimental Rheumatology 26(3): 461-463
Awwad, H.M.; Aboukhamis, I.A. 2010: Diagnostic Performances of Anti-Cyclic Citrullinated Peptide Antibodies type IgM, IgA and IgG in Syrian Patients with Rheumatoid Arthritis Clinical Laboratory 56(3-4): 95-102
Lequerré, T.; Richez, C. 2012: Anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: the best diagnostic tool but also a great interest in prognosis La Revue du Praticien 62(8): 1088-1089
Furst, D.E.; Schiff, M.H.; Fleischmann, R.M.; Strand, V.; Birbara, C.A.; Compagnone, D.; Fischkoff, S.A.; Chartash, E.K. 2003: Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis) Journal of Rheumatology 30(12): 2563-2571
Punzi, L.; di Maggio, C.; Mazzi, A.; Presacco, D.; Ruffatti, A.; Pellegrini, A.; Todesco, S. 1987: Radiological lesions of the hands in rheumatoid arthritis with rheumatoid factors and antinuclear antibodies Revue du Rhumatisme et des Maladies Osteo-Articulaires 54(7-9): 563-566
Vischer, T.L.; Jeannet, M. 1986: Lymphocytotoxic antibodies in rheumatoid arthritis: relation to HLA-DR2 and rheumatoid factors Clinical and Experimental Rheumatology 4(2): 139-142
Johnston, S.L.; Runge, L.A.; Johnson, J.L.; Phillips, P.E. 1985: Specificity of antibodies in rheumatoid arthritis. I. a controlled study of humoral antibodies to bovine nasal cartilage components Clinical and Experimental Rheumatology 3(3): 221-227
Sun, J.; Zhang, Y.; Liu, L.; Liu, G. 2014: Diagnostic accuracy of combined tests of anti cyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis: a meta-analysis Clinical and Experimental Rheumatology 32(1): 11-21
Yamane, T.; Hashiramoto, A.; Tanaka, Y.; Tsumiyama, K.; Miura, Y.; Shiozawa, K.; Chihara, K.; Shiozawa, S. 2008: Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor Journal of Rheumatology 35(3): 414-420
Goodwin, J.S.; Ceuppens, J.L.; Rodriguez, M.A. 1983: Administration of nonsteroidal anti-inflammatory agents in patients with rheumatoid arthritis. Effects on indexes of cellular immune status and serum rheumatoid factor levels JAMA 250(18): 2485-2488
Kim, D.-A.; Jearn, L.-H.; Kim, T.-Y. 2007: Antiperinuclear factor test is more useful than anti-Sa assay when used with anti-cyclic citrullinated peptide test in diagnosis of rheumatoid arthritis Journal of Rheumatology 34(9): 1944-1945